$1.07
$0.00 (0.00%)
End-of-day quote: 05/18/2024
NasdaqCM:ASRT
Assertio Holdings Competitors
| Ticker | Name | Exchange | Consensus | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| AZN | AstraZeneca PLC | LSE | Outperform | £121.10 | £165.99 | 0.00% | 16 | £187.73B |
| AMGN | Amgen | NasdaqGS | Outperform | $312.47 | $303.65 | 0.00% | 8 | $167.62B |
| PFE | Pfizer | NYSE | Outperform | $28.64 | $32.87 | 0.00% | 6 | $162.29B |
| GILD | Gilead Sciences Inc | NASDAQ | Outperform | $67.72 | $87.82 | 0.00% | 14 | $84.37B |
| 4568 | Daiichi Sankyo Company | TSE | Buy | ¥5.53k | ¥5.24k | 0.00% | 0 | ¥10.60T |
| 4502 | Takeda Pharmaceutical Company | TSE | Outperform | ¥4.13k | ¥4.74k | 0.00% | 0 | ¥6.48T |
| JAZZ | Jazz Pharmaceuticals | NasdaqGS | Outperform | $108.99 | $188.32 | 0.00% | 4 | $7.13B |
| HLUN A | H. Lundbeck A/S | CPSE | Outperform | kr37.40 | kr190.00 | 0.00% | 6 | kr36.60B |
| INSM | Insmed | NasdaqGS | Buy | $24.77 | $41.42 | 0.00% | 8 | $3.92B |
| PBH | Prestige Consumer Healthcare | NYSE | Outperform | $64.65 | $71.50 | 0.00% | 3 | $3.55B |
| BHC | Bausch Health Companies | NYSE | Hold | $6.77 | $9.50 | 0.00% | 5 | $2.55B |
| AMPH | Amphastar Pharmaceuticals | NasdaqGS | Outperform | $43.48 | $69.00 | 0.00% | 0 | $2.09B |
| SUPN | Supernus Pharmaceuticals | NasdaqGM | Outperform | $29.10 | $41.00 | 0.00% | 0 | $1.72B |
| ANIP | ANI Pharmaceuticals | NasdaqGM | Buy | $61.43 | $69.75 | 0.00% | 1 | $1.38B |
| IRWD | Ironwood Pharmaceuticals | NasdaqGS | Buy | $6.48 | $17.83 | 0.00% | 2 | $1.29B |
| COPN | Cosmo Pharmaceuticals N.V. | SWX | Buy | CHF72.90 | CHF76.55 | 0.00% | 0 | CHF1.14B |
| COLL | Collegium Pharmaceutical | NasdaqGS | Outperform | $32.47 | $37.75 | 0.00% | 1 | $1.24B |
| PCRX | Pacira BioSciences | NasdaqGS | Outperform | $30.82 | $47.90 | 0.00% | 6 | $1.23B |
| AQST | Aquestive Therapeutics | NasdaqGM | Buy | $3.11 | $6.33 | 0.00% | 0 | $307.71M |
| NKTR | Nektar Therapeutics | NasdaqCM | Hold | $1.76 | $2.75 | 0.00% | 2 | $301.14M |
| CHRS | Coherus BioSciences | NasdaqGM | Outperform | $2.12 | $10.86 | 0.00% | 3 | $255.37M |
| EBS | Emergent BioSolutions | NYSE | Outperform | $5.55 | $5.00 | 0.00% | 0 | $229.00M |
| ABEO | Abeona Therapeutics | NasdaqCM | Buy | $4.40 | $21.25 | 0.00% | 2 | $114.89M |
| DRRX | DURECT | NasdaqCM | Outperform | $0.93 | $6.75 | 0.00% | 2 | $33.21M |
| ALVIO | Valerio Therapeutics Société... | ENXTPA | - | 0.13€ | 1.30€ | 0.00% | 0 | 26.19€M |
| ENZN | Enzon Pharmaceuticals | OTCPK | - | $0.09 | $16.00 | 0.00% | 0 | $8.48M |
| ACOR | Acorda Therapeutics | NasdaqGS | - | $0.43 | $200.00 | 0.00% | 1 | $0.53M |
| DMK | DMK Pharmaceuticals | NasdaqCM | - | $0.03 | $1.50 | 0.00% | 0 | $0.35M |
